Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection].

The Korean journal of hepatology - 1 Sept 2008

Kang Myoung Joo, Jung Eun Uk, Park Sang Won, Choi Paul, Kim Ji Hyun, Park Sung Jae, Park Eun Taek, Lee Youn Jae, Lee Sang Hyuk, Seol Sang Yong

Abstract excerpt

BACKGROUND/AIMS: We assessed the efficacy and safety of pegylated interferon (peginterferon) plus ribavirin and identified the predictors of a sustained virologic response (SVR) in Korean patients with chronic hepatitis C virus infection. METHODS: A total of 192 patients with chronic hepatitis C, treated with both peginterferon (n=141) or conventional interferon (n=51) and ribavirin, were analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Data Interpretation, Statistical
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 18815455
DOI: 10.3350/kjhep.2008.14.3.318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection].PMID 18815455Read ↗

[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: a comparative study].Semantic proximity Read ↗

[Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C].Semantic proximity Read ↗

[Efficacy of peginterferon and ribavirin combination therapy of chronic hepatitis C: a pooled analysis].Semantic proximity Read ↗

Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C.Semantic proximity Read ↗

[Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C].Semantic proximity Read ↗

[Therapy of chronic hepatitis C].Semantic proximity Read ↗

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.Semantic proximity Read ↗

[Effectiveness and complications of combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C].Semantic proximity Read ↗

[Therapy of hepatitis C].Semantic proximity Read ↗

[Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C].Semantic proximity Read ↗

[Virological response of chronic hepatitis C management with peg-interferon alpha-2b and ribavirin].Semantic proximity Read ↗

Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.